New treatments for heart disease you need to know

Credit: Unsplash+

Heart disease, also known as cardiovascular disease, is a leading cause of death worldwide.

It encompasses a range of conditions, including coronary artery disease, heart failure, and arrhythmias.

While lifestyle changes, such as diet and exercise, are important for prevention and management, there are also a number of drugs and treatments available.

In recent years, there have been several new developments in the field. This review will discuss some of the most promising new drugs and treatments for heart disease.

New Cholesterol-Lowering Medications

High cholesterol is a significant risk factor for heart disease.

Statins have been the primary treatment for lowering cholesterol levels for many years, but recently, there have been new medications developed that are showing promise in reducing cholesterol levels even further.

One class of these new drugs is PCSK9 inhibitors, which work by blocking a protein that interferes with the liver’s ability to remove LDL, or “bad” cholesterol, from the blood.

PCSK9 inhibitors have been shown to lower LDL cholesterol levels by an additional 50% to 60%, even when used in combination with statins.

Another new cholesterol-lowering medication is bempedoic acid, which works by blocking an enzyme in the liver that is involved in cholesterol production.

Clinical trials have shown that bempedoic acid can reduce LDL cholesterol levels by up to 18%, and it can be taken in combination with statins for even greater efficacy.

New Antiplatelet Medications

Antiplatelet medications, such as aspirin and clopidogrel, are used to prevent blood clots and reduce the risk of heart attacks and strokes.

However, some people do not respond well to these medications, and there is a need for more effective options.

One new antiplatelet medication is ticagrelor, which works by blocking a protein involved in the activation of platelets.

Clinical trials have shown that ticagrelor is more effective than clopidogrel in reducing the risk of heart attacks, strokes, and cardiovascular death in patients with acute coronary syndromes.

New Heart Failure Medications

Heart failure is a condition in which the heart is unable to pump enough blood to meet the body’s needs. There have been several new medications developed in recent years that target different aspects of heart failure.

One new class of medications is called angiotensin receptor-neprilysin inhibitors (ARNIs), which work by blocking two different pathways involved in heart failure.

Clinical trials have shown that ARNIs can reduce the risk of hospitalization and death in patients with heart failure with reduced ejection fraction.

Another new medication is sacubitril/valsartan, which is an ARNI that has been shown to improve symptoms and reduce hospitalizations in patients with heart failure with reduced ejection fraction.

New Arrhythmia Treatments

Arrhythmias are abnormal heart rhythms that can be life-threatening. There have been several new treatments developed in recent years for different types of arrhythmias.

One new treatment for atrial fibrillation, the most common type of arrhythmia, is catheter ablation.

This procedure involves using a catheter to deliver radiofrequency energy to the heart tissue, creating scar tissue that disrupts the abnormal electrical signals causing the arrhythmia.

Clinical trials have shown that catheter ablation can be more effective than medication in restoring normal heart rhythm and reducing symptoms.

Another new treatment for ventricular arrhythmias, which can be a complication of heart failure, is cardiac resynchronization therapy with a defibrillator (CRT-D).

This involves implanting a device that coordinates the contractions of the heart’s chambers and can deliver an electrical shock if a life-threatening arrhythmia occurs.

Clinical trials have shown that CRT-D can reduce the risk of sudden cardiac death in patients with heart failure.


In conclusion, new drugs and treatments for heart disease are constantly being developed and studied, offering hope for those living with this condition.

From novel therapies targeting cholesterol and inflammation to advancements in surgical techniques and medical devices, the field of cardiovascular medicine continues to make great strides in improving patient outcomes and quality of life.

However, it is important to note that lifestyle modifications such as healthy eating habits, regular exercise, and avoiding tobacco use remain essential in preventing and managing heart disease.

As always, individuals should work closely with their healthcare provider to determine the best course of treatment for their specific condition and medical history.

If you care about heart health, please read studies about how eating eggs can help reduce heart disease risk, and herbal supplements could harm your heart rhythm.

For more information about heart health, please see recent studies about supplements that could help prevent heart disease, stroke, and results showing that a year of committed exercise in middle age reversed worrisome heart failure.

Copyright © 2023 Knowridge Science Report. All rights reserved.